InvestorsHub Logo
Followers 49
Posts 11287
Boards Moderated 0
Alias Born 06/15/2014

Re: Whalatane post# 169

Thursday, 05/02/2024 10:48:01 PM

Thursday, May 02, 2024 10:48:01 PM

Post# of 286
Thanks Kiwi. Interesting piece from their pr:

“ Among the 77 nephrologists surveyed, 98% rate XPHOZAH as an advance over currently available hyperphosphatemia therapies. 56% of surveyed nephrologists report initiating a patient on XPHOZAH, and among those reported users, 98% report satisfaction with treatment.”

Without Medicare coverage combined with giving the product away seems like a tough road making moolah on this.

As far as UNCY undercutting them, you seemed to indicate in a prior post that you thought UNCY would seek to sell itself before starting a marketing effort? You think that they may be already sending out feelers?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent UNCY News